Literature DB >> 15037488

Clinical considerations in premenopausal osteoporosis.

Margaret L Gourlay1, Sue A Brown.   

Abstract

Osteoporosis can occur at any age. In premenopausal osteoporosis, full achievement of peak bone mass may be curtailed, and accelerated bone loss may occur in young adulthood. Premenopausal osteoporosis may be associated with chronic glucocorticoid therapy, prolonged amenorrhea, anorexia nervosa, rheumatoid arthritis, and diseases that affect calcium and vitamin D metabolism. Lesser degrees of bone loss may be associated with common conditions such as dieting, low calcium intake, smoking, and oligomenorrhea. Owing to a paucity of prospective studies on screening and treatment in younger age groups, few practice recommendations exist to guide the management of osteoporosis in young adults. We review the most important clinical concerns in premenopausal osteoporosis, including measurement of bone mass, normal bone accrual, risk factors for premature bone loss, clinical outcomes, and management issues. We emphasize clinically relevant information for primary care physicians, who are usually the first to encounter premenopausal patients with risk factors for early bone loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037488     DOI: 10.1001/archinte.164.6.603

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  20 in total

1.  Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; David W Dempster; Robert R Recker; Emily M Stein; Joan M Lappe; Hua Zhou; Andreas J Wirth; G Harry van Lenthe; Thomas Kohler; Alexander Zwahlen; Ralph Müller; Clifford J Rosen; Serge Cremers; Thomas L Nickolas; Donald J McMahon; Halley Rogers; Ronald B Staron; Jeanette LeMaster; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

Review 2.  Treatment of low bone mass in premenopausal women: when may it be appropriate?

Authors:  Edward S Leib
Journal:  Curr Osteoporos Rep       Date:  2005-03       Impact factor: 5.096

3.  Relationship of obesity with osteoporosis.

Authors:  Lan-Juan Zhao; Yong-Jun Liu; Peng-Yuan Liu; James Hamilton; Robert R Recker; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2007-02-13       Impact factor: 5.958

4.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

5.  Predictors of bone mineral density in african-american and caucasian college-aged women.

Authors:  Andrea K Johnson; M Allison Ford; Tamekia L Jones; Vinayak K Nahar; Jeffrey S Hallam
Journal:  Health Promot Perspect       Date:  2015-03-29

6.  The development of inter-strain variation in cortical and trabecular traits during growth of the mouse lumbar vertebral body.

Authors:  M A Ramcharan; M E Faillace; Z Guengerich; V A Williams; K J Jepsen
Journal:  Osteoporos Int       Date:  2016-10-12       Impact factor: 4.507

7.  Evaluation and management of the premenopausal woman with low BMD.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

8.  Effects of taurine supplementation on bone mineral density in ovariectomized rats fed calcium deficient diet.

Authors:  Mi-Ja Choi
Journal:  Nutr Res Pract       Date:  2009-06-30       Impact factor: 1.926

9.  Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; X Sherry Liu; Emily M Stein; Donald J McMahon; Halley F Rogers; Jeanette Lemaster; Robert R Recker; Joan M Lappe; X Edward Guo; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

10.  Central QCT reveals lower volumetric BMD and stiffness in premenopausal women with idiopathic osteoporosis, regardless of fracture history.

Authors:  Adi Cohen; Thomas F Lang; Donald J McMahon; X Sherry Liu; X Edward Guo; Chiyuan Zhang; Emily M Stein; David W Dempster; Polly Young; Isra Saeed; Joan M Lappe; Robert R Recker; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2012-09-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.